First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels

Prenatal Diagnosis

Volumn 25, Issue 8, 2005, Pages 693-699

  Cowans, N J ^a   Spencer, K ^a  

^a HAROLD WOOD HOSPITAL   (United Kingdom)

Author keywords

AFP; Down's syndrome; Free hCG; PAPP A; Placental volume; Prenatal screening; Trisomy 21

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; HEMOGLOBIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AFRICAN CARIBBEAN; ANEMIA; ARTICLE; ASIAN; BODY HEIGHT; BODY WEIGHT; CAUCASIAN; CHROMOSOME ABERRATION; CONTROLLED STUDY; DOWN SYNDROME; ETHNOLOGY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC RISK; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MEDICAL RECORD; PLACENTA WEIGHT; PLASMA VOLUME; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; TRISOMY 21;

ADULT; ALPHA-FETOPROTEINS; ANEMIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME ABERRATIONS; DOWN SYNDROME; ETHNIC GROUPS; FEMALE; GESTATIONAL AGE; HEMOGLOBINS; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 23844531540     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1191     Document Type: Article

References (24)

1. Bartha JL, Omar KM, Soothill PW. 2004. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin. Prenat Diagn 24: 609-612.
2. Beekhuis JR, Van Lith JM, De Wolf BT, Mantingh A. 1992. Increased maternal serum alpha-fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down Syndrome. Prenat Diagn 12: 643-647.
3. Boyd PA, Keeling JW. 1986. Raised maternal serum alpha-fetoprotein in the absence of fetal abnormality-placental findings. A quantitative morphometric study. Prenat Diagn 6: 369-373.
4. Dowdle W. 1989. CDC criteria for anemia in children and childbearing-aged women. MMWR Morb Mortal Wkly Rep 38: 400-404.
5. Holding S, Cuckle H. 1995. Full blood count and second trimester markers of Down's Syndrome. Prenat Diagn 15: 982-984.
6. Howe DT, Wheeler T, Osmond C. 1995. The influence of maternal haemoglobin and ferritin on mid-pregnancy placental volume. Br J Obstet Gynaecol 102: 213-219.
7. Katz VL, Chescheir NC, Cefalo RC. 1990. Unexplained elevations of maternal serum alpha-fetoprotein. Obstet Gynecol Surv 45: 719-726.
8. McLaughlin B, Kevany J. 1982. Haemoglobin concentration in pregnancy: relationships with maternal age and birth weight. Ir J Med Sci 151: 71-74.
9. McMullin MF, White R, Lappin T, Reeves J, MacKenzie G. 2003. Haemoglobin during pregnancy: relationship to erythropoietin and haematinic status. Eur J Haematol 71: 44-50.
10. Metzenbauer M, Hafner E, Schuchter K, Philipp K. 2002. First-trimester placental volume as a marker for chromosomal anomalies: preliminary results from an unselected population. Ultrasound Obstet Gynecol 19: 240-242.
11. Metzenbauer M, Hafner E, Hoefinger D, et al. 2001. Three-dimensional ultrasound measurement of placental volume in early pregnancy: method and correlation with biochemical placenta parameters. Placenta 22: 602-606.
12. Michailidis GD, Morris RW, Mamopoulos A, Papageorgiou P, Economides DL. 2002. The influence of maternal hematocrit on placental development from the first to the second trimesters of pregnancy. Ultrasound Obstet Gynecol 20: 351-355.
13. Murphy JF, O'Riordan J, Newcombe RG, Coles EC, Pearson JF. 1986. Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet 1(8488): 992-995.
14. Neveux LM, Palomaki GE, Larivee DA, Knight GJ, Haddow JE. 1996. Refinements in managing maternal weight adjustment for interpreting screening results. Prenat Diagn 23: 851-855.
15. Spencer K, Bindra R, Nicolaides KH. 2003. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 23: 851-855.
16. Spencer K, Bindra R, Cacho AM, Nicolaides KH. 2004. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 24: 169-173.
17. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13: 231-237.
18. Spencer K, Heath V, Flack N, Ong C, Nicolaides KH. 2000. First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21. Prenat Diagn 20: 635-639.
19. Spencer K, Heath V, El-Sheikhah A, Ong CYT, Nicolaides KH. 2005. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 25: 365-369.
20. van Buul EJ, Steegers EA, Jongsma HW, Eskes TK, Thomas CM, Hein PR. 1995. Haematological and biochemical profile of uncomplicated pregnancy in nulliparous women; a longitudinal study. Neth J Med 46: 73-85.
21. WaId NJ, Kennard A, Hackshaw A, McGuire A. 1998. Antenatal screening for Down's Syndrome. Health Technol Assess Rep 2(1): Whole Issue.
22. Waller DK, Lustig LS, Cunningham GC, Golbus MS, Hook EB. 1991. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 325: 6-10.
23. Wheeler T, Sollero C, Alderman S, Landen J, Anthony F, Osmond C. 1994. Relation between maternal haemoglobin and placental hormone concentrations in early pregnancy. Lancet 343: 511-513.
24. Whittaker PG, Lind T. 1993. The intravascular mass of albumin during human pregnancy: a serial study in normal and diabetic women. Br J Obstet Gynaecol 100: 587-592.